Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
Established in 1994, Jamjoom Pharmaceuticals Factory Company, headquartered in Jeddah, Saudi Arabia, is a key player in the production and commercialization of medicinal products. The firm serves markets both within the Kingdom of Saudi Arabia and across various international regions. Its extensive product portfolio addresses a wide array of therapeutic needs, covering ophthalmology, dermatology, gastrointestinal issues, cardiovascular health, central nervous system disorders, as well as general medicine, over-the-counter remedies, and nutraceuticals/consumer health products.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, o
Target Price
The average target price of 4015.SR is 161 and suggests 2% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation